Bringing high-quality, novel therapeutics and healthcare solutions to Southeast Asia and the Gulf through strategic regional partnerships.
Myanmar
United Arab Emirates
Cambodia
Philippines
Our home market, where 23ANDME registers, promotes and distributes certified pharmaceuticals to doctors, hospitals and pharmacies nationwide — the commercial engine behind every regional partnership.
Through our UAE-registered arm ABCBIO Health FZCO, the group contracts with international manufacturers and consolidates supply from one of the world's leading pharmaceutical trade hubs before it reaches regional markets.
23ANDME Group has established a strategic commercial partnership with Telpha Cambodia to expand the availability of novel therapeutics across the Kingdom. Leveraging our network of international manufacturing associates and sourcing partners, we supply high-standard formulations tailored to Cambodia's clinical and market needs.
Expanding our footprint in Southeast Asia, 23ANDME Group is actively executing product registrations with national regulatory authorities in the Philippines alongside allied local partners. To support long-term growth, the group is establishing a dedicated regional marketing office to manage brand building, distributor relations and physician engagement.
Active product registrations and FDA dossier submissions across multiple markets.
Trusted in-country partners delivering reliable reach to clinicians and pharmacies.
Consolidated procurement through our UAE trade hub for high-standard formulations.
If you're a manufacturer or distributor looking to reach Southeast Asia and the Gulf, our regional network — and our procurement partner ABCBIO Health FZCO — are ready to talk.
Partner With Us in Emerging Markets